Cargando…
A Novel Therapeutic and Prophylactic Vaccine (HVJ-Envelope / Hsp65 DNA + IL-12 DNA) against Tuberculosis Using the Cynomolgus Monkey Model
We have developed a novel tuberculosis (TB) vaccine; a combination of the DNA vaccines expressing mycobacterial heat shock protein 65 (HSP65) and interleukin 12 (IL-12) delivered by the hemagglutinating virus of Japan (HVJ)-envelope and –liposome (HSP65 + IL-12/HVJ). An IL-12 expression vector (IL-1...
Autores principales: | Okada, M, Kita, Y, Nakajima, T, Kanamaru, N, Hashimoto, S, Nishida, Y, Nakatani, H, Takao, K, Kishigami, C, Nishimatsu, S, Sekine, Y, Inoue, Y, Nagasawa, T, Kaneda, Y, Yoshida, S, Matsumoto, M, Paul, Saunderson, Tan, E.V., Cruz, E.C.Dela, N. McMurray, D, Sakatani, M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7129898/ https://www.ncbi.nlm.nih.gov/pubmed/32288910 http://dx.doi.org/10.1016/j.provac.2010.03.007 |
Ejemplares similares
-
A Novel Therapeutic and Prophylactic Vaccine against Tuberculosis Using the Cynomolgus Monkey Model and Mouse Model
por: Okada, M., et al.
Publicado: (2011) -
Novel Prophylactic Vaccine Using a Prime-Boost Method and Hemagglutinating Virus of Japan-Envelope against Tuberculosis
por: Okada, Masaji, et al.
Publicado: (2011) -
Phase I/II clinical trial to assess safety and efficacy of intratumoral and subcutaneous injection of HVJ-E in castration-resistant prostate cancer patients
por: Fujita, K, et al.
Publicado: (2017) -
A new therapy for highly effective tumor eradication using HVJ-E combined with chemotherapy
por: Kawano, Hirokazu, et al.
Publicado: (2007) -
Long-term blood glucose monitoring with implanted telemetry device in conscious and stress-free cynomolgus monkeys
por: Wang, B., et al.
Publicado: (2017)